1Raymond B. Weiss,Gisele Sarosy,Kathleen Clagett-Carr,Marianne Russo,Brian Leyland-Jones. Anthracycline analogs The past, present, and future[J] 1986,Cancer Chemotherapy and Pharmacology(3):185～197
2Dr F. Ganzina,M. A. Pacciarini,N. Pietro. Idarubicin (4-demethoxydaunorubicin)[J] 1986,Investigational New Drugs(1):85～105
3Franca Formelli,Carmen Pollini,Anna Maria Casazza,Aurelio Marco,Adriano Mariani. Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors[J] 1981,Cancer Chemotherapy and Pharmacology(3):139～144
4S. K. Carter. The clinical evaluation of analogs — III. Anthracyclines[J] 1980,Cancer Chemotherapy and Pharmacology(1):5～10
5R. Baurain,D. Deprez-De Campeneere,A. Trouet. Distribution and metabolism of rubidazone and daunorubicin in mice[J] 1979,Cancer Chemotherapy and Pharmacology(1):37～41
